These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31064048)

  • 21. PTH increases jaw mineral density in a rabbit model of osteoporosis.
    Bellido M; Lugo L; Castañeda S; Roman-Blas JA; Rufián-Henares JA; Navarro-Alarcón M; Largo R; Herrero-Beaumont G
    J Dent Res; 2010 Apr; 89(4):360-5. PubMed ID: 20177133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
    Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
    J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of osteoporosis with recombinant parathyroid hormone, utilisation of total body DXA to observe treatment effects on total body composition and factors determining response to therapy.
    Siddique N; Fallon N; Steen G; Walsh JB; Casey MC
    Ir J Med Sci; 2019 May; 188(2):505-515. PubMed ID: 30032480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-resorptive therapies for osteoporosis.
    Reid IR
    Semin Cell Dev Biol; 2008 Oct; 19(5):473-8. PubMed ID: 18760372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osteoblast as a target of anti-osteoporotic treatment.
    Corrado A; Sanpaolo ER; Di Bello S; Cantatore FP
    Postgrad Med; 2017 Nov; 129(8):858-865. PubMed ID: 28770650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New therapeutic targets for osteoporosis: beyond denosumab.
    Lim V; Clarke BL
    Maturitas; 2012 Nov; 73(3):269-72. PubMed ID: 22925430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging therapeutic targets for osteoporosis treatment.
    Chen M; Qiao H; Su Z; Li H; Ping Q; Zong L
    Expert Opin Ther Targets; 2014 Jul; 18(7):817-31. PubMed ID: 24766518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of osteoporosis with parathyroid hormone].
    Syversen U; Halse JI
    Tidsskr Nor Laegeforen; 2008 Jan; 128(1):39-41. PubMed ID: 18183056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two osteoporosis treatments deemed best for brittle bones. Sequential therapy of two drugs, bisphosphonates and PTH, produces the best effects on bone strength.
    Health News; 2006 Feb; 12(2):3-4. PubMed ID: 16453932
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug insight: Existing and emerging therapies for osteoporosis.
    Mulder JE; Kolatkar NS; LeBoff MS
    Nat Clin Pract Endocrinol Metab; 2006 Dec; 2(12):670-80. PubMed ID: 17143314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Next generation selective estrogen receptor modulators].
    Chaki O
    Clin Calcium; 2006 Jan; 16(1):145-52. PubMed ID: 16397365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New horizons in osteoporosis therapies.
    Harsløf T; Langdahl BL
    Curr Opin Pharmacol; 2016 Jun; 28():38-42. PubMed ID: 26989807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current perspectives on parathyroid hormone (PTH) and PTH-related protein (PTHrP) as bone anabolic therapies.
    Esbrit P; Alcaraz MJ
    Biochem Pharmacol; 2013 May; 85(10):1417-23. PubMed ID: 23500550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parathyroid hormone and its analogues--molecular mechanisms of action and efficacy in osteoporosis therapy.
    Misiorowski W
    Endokrynol Pol; 2011; 62(1):73-8. PubMed ID: 21365583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
    Wensel TM; Iranikhah MM; Wilborn TW
    Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Prevention and Therapy of Osteoporosis: A Review on Emerging Trends from Hormonal Therapy to Synthetic Drugs to Plant-Based Bioactives.
    Gupta T; Das N; Imran S
    J Diet Suppl; 2019; 16(6):699-713. PubMed ID: 29985715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomics of osteoporotic fractures.
    Riancho JA; Pérez-Campo FM
    Methods Mol Biol; 2014; 1175():661-70. PubMed ID: 25150879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of osteopenia and osteoporosis in anorexia nervosa: a systematic review of the literature.
    Mehler PS; MacKenzie TD
    Int J Eat Disord; 2009 Apr; 42(3):195-201. PubMed ID: 18951456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perioperative Medical Management of Spine Surgery Patients With Osteoporosis.
    Lubelski D; Choma TJ; Steinmetz MP; Harrop JS; Mroz TE
    Neurosurgery; 2015 Oct; 77 Suppl 4():S92-7. PubMed ID: 26378362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.